Hint mode is switched on Switch off
For swift navigation between sections

Organization: Roche Holding AG
LEI 549300U41AUUVOAAOB37, SWIFT ROCHCHBHXXX

Organization name
Roche Holding AG
Country name
Switzerland
Country of registration
Switzerland
Industry
Pharmaceutical Preparation and Biotechnology
Bond debt
5,824 mln USD

explore the most comprehensive database

800 000

bonds globally

Over 400

pricing sources

80 000

stocks

9 000

ETF

track your portfolio in the most efficient way
Bond Search
Watchlist
Excel ADD-IN
Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 700 000 bonds, stocks & ETFs; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Latest data on

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Roche Holding AG operates in the pharmaceuticals and diagnostics businesses in Switzerland, European Union, and internationally. It discovers, develops, and delivers diagnostic and therapeutic products and services that enable patients and healthcare professionals in the detection, prevention, diagnosis, treatment, and treatment monitoring of diseases. The company is also involved in the provision of pharmaceutical products for various therapeutic areas comprising oncology, virology, inflammation, metabolic disorders, and central nervous system. In addition, it offers a portfolio of diagnostics products, such as blood glucose meters for diabetes patients; point-of-care testing devices for use in doctors offices; high-throughput analyzers for hospitals and commercial diagnostic laboratories; and start-of-the-art instruments and reagents for life science research.

Awards

News

30/11/2023 New issues: Issuer Roche Holding AG released international bonds (XS2726331932, XS2726335099) in the amount of EUR 600, EUR 900 mln maturing in 2027, 2036 respectively.
30/10/2023 Fitch Ratings affirms Roche Holding AG at "AA" (LT Int. Scale (foreign curr.) credit rating); outlook stable
19/09/2023 S&P Global Ratings affirms Roche Holding AG at "AA" (Foreign Currency LT credit rating); outlook stable
19/09/2023 S&P Global Ratings affirms Roche Holding AG at "AA" (Local Currency LT credit rating); outlook stable
27/02/2023 New issue: Issuer Roche Holding AG issued international bonds (XS2592088236) with the coupon rate of 3.204% in the amount of EUR 750 mln maturing in 2029
All organization news

Documentation

IFRS/US GAAP reports

2023
II q eng
IV q eng
2022
II q eng
IV q eng
2021
II q eng
IV q eng
2020
II q eng
IV q eng
2019
II q eng
IV q eng
2018
II q eng
IV q eng
Show all Hide
Authorization required
You need to request access

Affiliates

Stocks

Latest issues

Show all

Bond debt by currency

Show more Hide

Codes

  • LEI
    549300U41AUUVOAAOB37
  • SWIFT
    ROCHCHBHXXX
  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • ICB
    4,500 Health Care
  • CIK
    0000896566

Credit and ESG Ratings

Macroeconomic Indicators - Roche Holding AG

Registration is required to get access.